1
Clinical Trials associated with Multivirus-specific T Cells(Peking University People's Hospital)An Exploratory Clinical Study of Multivirus-specific T Cells in the Treatment of Refractory Cytomegalovirus and/or Epstein-Barr Virus Infection After Allogeneic Hematopoietic Stem Cell Transplantation
To evaluate the safety and tolerability of partial HLA-matched VSTs against both CMV and EBV viruses in recipients of allogeneic hematopoietic stem cells with refractory viral infections (CMV and/or EBV).
Preliminary evaluation of the efficacy of partial HLA-matched VSTs against both CMV and EBV viruses in recipients of allogeneic hematopoietic stem cells with refractory viral infections (CMV and/or EBV); To monitor the duration and expansion of multi-virus VSTs cells after infusion.
100 Clinical Results associated with Multivirus-specific T Cells(Peking University People's Hospital)
100 Translational Medicine associated with Multivirus-specific T Cells(Peking University People's Hospital)
100 Patents (Medical) associated with Multivirus-specific T Cells(Peking University People's Hospital)
100 Deals associated with Multivirus-specific T Cells(Peking University People's Hospital)